Medication before angioplasty for heart attack patients
Part of Heart & circulation clinical trials.
This trial tests whether giving a medication before angioplasty reduces damage to the heart muscle in people having a severe heart attack. It may help improve blood flow and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a heart attack and arrived at the hospital within 24 hours of symptoms starting.
- The blocked artery has a large blood clot, confirmed by the doctor during the procedure.
- The procedure will be done through the wrist (radial artery), not the groin.
- You have not received clot-busting medication (fibrinolysis) for this heart attack.
- You can have an MRI of the heart (cardiac MRI) — so no metal heart valves, certain pacemakers/defibrillators, or severe claustrophobia.
- You are able to give informed consent (not unconscious or comatose).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests whether using a special device to remove blood clots during emergency heart artery opening can improve outcomes for people having a major heart attack on the front of the heart. It is for patients who get to the hospital quickly after symptoms start.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
This study looks at how well the heart muscle recovers after emergency angioplasty (a procedure to open blocked arteries) in people having their first major heart attack. It uses special heart scans and ECGs to check blood flow and muscle health, aiming to improve future treatments.
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.